Press Releases

SMALL BONE INNOVATIONS, INC. TO SPONSOR CIRCULAR FIXATION WORKSHOP FOR PODIATRIC SURGEONS ON AUGUST 29TH IN INDIANAPOLIS

• Raises Series D round of $108mm - one of the largest private equity capital financings for an orthopedic company
• Raises Series C round of $36mm
• Retires $20 million credit facility

NEW YORK, NY: August 23, 2009 - Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone & joint sector, is sponsoring a comprehensive workshop in the use of circulator fixation technology on August 29th at the Indianapolis Marriott Hotel .

Currently, more than 30 podiatric surgeons have registered for this one-day intensive training course. Essentials of Circular Fixation is intended to teach circular fixation techniques utilizing the SBi RingFIX tm system for the treatment of various foot and ankle indications. Topics and Labs include: Biomechanics, Safe Zones, Charcot Foot, Triple Arthrodesis, Ankle Fusion, Ankle Distraction Arthroplasty, and management of patients.

SBi plans to host continuing educational programs throughout the country to enable podiatric foot and ankle surgeons to use RingFIX tm and the RingFIX tm RAD technologies for the preservation of diabetic patients’ lower limbs and other conditions that require the maintenance of the ankle joint and range of motion for the post-traumatic ankle arthritis patient.

This SBi sponsored program will be led by two of the nation’s leading exponents of circular fixation: Guido LaPorta, DPM, FACFAS, the Chief of Foot & Ankle Surgery and Director of Podiatric Medical Education at the Scranton, PA Community Medical Center; and Gary La Bianco, DPM, of the Foot & Ankle Institute of Ohio at Dayton.

“As the aging population grows, podiatric surgeons are seeing significant increases in patients with late stage arthritis and an alarming surge in diabetics with severe foot ulceration and bone disease. Use of the latest circular fixation devices is one of the most effective methods of preventing chronic conditions and preserving limb function,” Dr. LaPorta said.

Anthony G. Viscogliosi, Chairman & CEO of SBi, commented: “Drs. LaPorta and LaBianco are among the most respected and innovative lower limb specialists in the U.S. This event will make an extremely valuable contribution to the continuing education of podiatric foot and ankle surgeons with the mission of bringing life-changing technology to many thousands of patients suffering from advanced diabetic foot pathology, and late stage arthritis in the ankle joint.”

“Our sponsorship of the event reflects SBi’s value creation thesis of being data-driven, surgeon-centric and patient focused in addressing the unmet clinical needs of foot & ankle surgeons,” he added.

For details and registration for this course contact: Bill Gonzalez at bgonzalez@totalsmallbone.com

Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France and Donaueschingen, Germany, among other locations worldwide.

Forward-looking statements
This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting SBi’s business including increased competition; the ability of SBi to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.